A molecular assay designed for cervical cancer screening applications utilizing Atila BioSystems nucleic acid amplification chemistry.
Manufactured by
United States
Atila BioSystems is an in vitro diagnostics (IVD) manufacturer specializing in molecular diagnostic tests and reagents across infectious disease, genetic screening, cancer testing, and viral detection. The company develops multiplex testing solutions, controls, and nucleic acid-based reagents for clinical laboratory and research applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Attogen Biomedical(Suzhou)Ltd.Inc
China · 1 relevant product
shanghai rendu biotechnology co.,ltd.
China · 5 relevant products
Intelligenome
United States · 1 relevant product
Qassay
United States · 1 relevant product
Deaou Gene Technology Co.,Ltd
China · 2 relevant products
Biopsense Oy
Finland · 1 relevant product
APPOLON BIOTECK SAS
France · 2 relevant products
PlexBio Co., Ltd.
Taiwan · 1 relevant product
Suzhou Molarray Co., Ltd.
China · 1 relevant product
Burning Rock Dx Co. Ltd.
China · 1 relevant product
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 75 closest product alternatives
Attogen Biomedical(Suzhou)Ltd.Inc · China
Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.
shanghai rendu biotechnology co.,ltd. · China
AmpSure® HPV Assay is an in vitro diagnostic test for the detection and identification of human papillomavirus RNA in clinical specimens. The assay leverages advanced RNA detection technology to deliver precise results for cervical cancer screening and HPV-related disease management. Designed for clinical laboratory use with optimized sensitivity and specificity.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
shanghai rendu biotechnology co.,ltd. · China
The AmpSure® HPV 16/18 Genotype Assay is an in vitro diagnostic test for detecting and genotyping human papillomavirus (HPV) types 16 and 18 in clinical specimens. This molecular assay enables precise identification of high-risk HPV strains associated with cervical cancer and related malignancies, supporting clinical screening and risk stratification protocols.
APPOLON BIOTECK SAS · France
A molecular diagnostic test kit for HPV screening recommended by the CNR Papillomavirus for cervical cancer detection. The test has been validated through rigorous clinical studies demonstrating sensitivity, specificity, and compliance with international standards.
PlexBio Co., Ltd. · Taiwan
Comprehensive collection of molecular diagnostic assays for cancer detection and analysis. Includes advanced testing solutions for lung cancer and other oncological applications.
Suzhou Molarray Co., Ltd. · China
A molecular assay for the detection of specific genetic sequences or mutations in patient samples. The test is used in genetic screening, disease diagnosis, and personalized medicine applications.
Burning Rock Dx Co. Ltd. · China
Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A point-of-care testing assay that detects and differentiates high-risk HPV subtypes. Enables rapid screening for cervical cancer risk at the point of care.
63 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products